FibroBiologics, Inc.
FBLG
$0.26
-$0.02-5.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.89M | 4.87M | 8.85M | 8.67M | 13.99M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.46M | 373.00K | 1.33M | 642.00K | 225.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 18.00K | 18.00K |
| Total Current Assets | 6.35M | 5.24M | 10.18M | 9.33M | 14.23M |
|
|
|||||
| Total Current Assets | 6.35M | 5.24M | 10.18M | 9.33M | 14.23M |
| Net Property, Plant & Equipment | 3.22M | 3.46M | 3.68M | 2.10M | 2.22M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 48.00K | 48.00K | 48.00K | -- | -- |
| Total Assets | 9.62M | 8.74M | 13.91M | 11.43M | 16.45M |
|
|
|||||
| Total Accounts Payable | 945.00K | 1.07M | 1.80M | 1.42M | 2.70M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 4.57M | 8.07M | 5.84M | 9.17M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 706.00K | 643.00K | 627.00K | 412.00K | 401.00K |
| Total Finance Division Other Current Liabilities | 108.00K | 437.00K | 470.00K | 543.00K | 460.00K |
| Total Other Current Liabilities | 108.00K | 437.00K | 470.00K | 543.00K | 460.00K |
| Total Current Liabilities | 1.76M | 6.72M | 10.96M | 8.21M | 12.73M |
|
|
|||||
| Total Current Liabilities | 1.76M | 6.72M | 10.96M | 8.21M | 12.73M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 4.57M | 8.07M | 5.84M | 9.17M |
| Capital Leases | 1.70M | 1.90M | 2.08M | 865.00K | 984.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.46M | 8.62M | 13.05M | 9.08M | 13.71M |
|
|
|||||
| Common Stock & APIC | 60.32M | 51.05M | 46.00M | 42.83M | 38.25M |
| Retained Earnings | -54.16M | -50.92M | -45.14M | -40.48M | -35.52M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 6.16M | 125.00K | 860.00K | 2.35M | 2.74M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.16M | 125.00K | 860.00K | 2.35M | 2.74M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.16M | 125.00K | 860.00K | 2.35M | 2.74M |
|
|
|||||